MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
29.04
-2.93 (-9.16%)
At close: Apr 28, 2026, 4:00 PM EDT
29.25
+0.21 (0.72%)
Pre-market: Apr 29, 2026, 9:09 AM EDT
MBX Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,381 | 1,416 | 616 | - | - |
| Market Cap Growth | 559.18% | 129.95% | - | - | - |
| Enterprise Value | 1,008 | 1,025 | 339 | - | - |
| Last Close Price | 29.04 | 31.54 | 18.43 | - | - |
| PB Ratio | 3.53 | 3.84 | 2.39 | - | - |
| P/TBV Ratio | 3.74 | 3.84 | 2.39 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -1.02 | -1.01 | -1.02 |
| Net Debt / EBITDA Ratio | 3.82 | 3.82 | 3.86 | 2.29 | 1.67 |
| Net Debt / FCF Ratio | 4.56 | 4.56 | 4.72 | 2.50 | 1.78 |
| Quick Ratio | 24.26 | 24.26 | 23.78 | 20.60 | 12.42 |
| Current Ratio | 24.62 | 24.62 | 24.19 | 21.26 | 12.89 |
| Return on Equity (ROE) | -27.76% | -27.76% | -36.71% | -53.75% | - |
| Return on Assets (ROA) | -18.75% | -18.75% | -24.17% | -34.14% | - |
| Return on Capital Employed (ROCE) | -26.50% | -26.50% | -26.50% | -44.00% | -60.40% |
| Earnings Yield | -6.30% | -6.14% | -10.05% | - | - |
| FCF Yield | -5.93% | -5.78% | -9.02% | - | - |
| Buyback Yield / Dilution | -243.01% | -243.01% | -944.70% | -52.73% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.